Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/60910
Title: Comparative analysis of lipid profile management in ischaemic heart disease
Authors: Zarb, Maia
Xuereb, Robert G.
Wirth, Francesca
Azzopardi, Lilian M.
Keywords: Coronary heart disease -- Patients
Statins (Cardiovascular agents)
Coronary heart disease -- Case studies
Heart -- Diseases
Issue Date: 2020
Publisher: University of Malta. Department of Pharmacy
Citation: Zarb, M., Xuereb, R. G., Wirth, F., & Azzopardi, L. M. (2020). Comparative analysis of lipid profile management in ischaemic heart disease. FIP Virtual Event : Living and Learning Through the Covid-19 Pandemic - Global Reflections.
Abstract: According to the 2019 European statistics, 4.1 million deaths in Europe are caused by cardiovascular disease, with ischaemic heart disease (IHD) being a leading cause of mortality. The European Society of Cardiology (ESC) guidelines for the management of dyslipidemias recommended a target low density lipoprotein cholesterol (LDL-C) goal of ≤1.4mmol/L or ≥50 %relative reduction. Patients with documented cardiovascular disease and elevated individual risk factors are candidates for early intervention with higher intensity statins alongside lifestyle modifications.
URI: https://www.um.edu.mt/library/oar/handle/123456789/60910
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Zarb - Comparative Analysis of Lipid Profile Management in Ischaemic Heart Disease.pdf257.72 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.